Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression

meizhu chen; changli tu; Cuiyan Tan; Xiaobin Zheng; xiaohua wang; jian wu; Yiying Huang; zhenguo wang; yan yan; zhonghe li; hong shan; Jing Liu; jin huang

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. According to the clinical characteristics of COVID-19, early and timely intervention is important. In this study, none of the 97 patients had basic diseases of immune dysfunction. Therefore, it is considered that immune dysfunction and internal environmental disorder are transient after the virus infection. So in the treatment, we mainly focused on symptomatic and supportive treatment in the early stage, such as adequate supplementation of albumin, plasma and potassium, in order to maintain the stability of the intracellular environment and adequately reactivate body immunity to clean up sars-cov-2 by themselves, which is consistent with Lei Zhang's opinion [18] .